MétaCan
Menu
Back to cohort
Record W4413859329 · doi:10.1093/neuonc/noaf140

Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium

2025· review· en· W4413859329 on OpenAlexafffund
Chetan Bettegowda, Houtan Noushmehr, Alessandra Affinito, Manmeet S. Ahluwalia, Olaf Ansorge, Katayoun Ayasoufi, Stephen Bagley, Jill S. Barnholtz‐Sloan, Myron G. Best, Dieta Brandsma, Chaya Brodie, Anke Brüning‐Richardson, Ana Valeria Castro, Susan Chang, Gerolama Condorelli, Ahmad Daher, Vineet Datta, John de Groot, Pim J. French, Evanthia Galanis, Anna Golebiewska, Petra Hamerlik, C. Oliver Hanemann, Matthias Holdhoff, Jason T. Huse, Mustafa Khasraw, Suzanne LeBlang, Beatrice Melin, Florent Moulière, Claire O’Leary, Janusz Rak, Amitava Ray, Stephen Robinson, Ola Rominiyi, Federico Roncaroli, Roberta Rudà, Joan Seoane, Nik Sol, Martin J. van den Bent, Michael A. Vogelbaum, Tobias Walbert, Colin Watts, Tobias Weiß, Michael Weller, Patrick Y. Wen, Victoria Wykes, Stephen Yip, Susan Short, Riccardo Soffietti

Bibliographic record

VenueNeuro-Oncology · 2025
Typereview
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer Genomics and Diagnostics
Canadian institutionsUniversity of British ColumbiaMcGill University
FundersUniversity of California, San FranciscoUniversity of Texas MD Anderson Cancer CenterMedacDaiichi Sankyo EuropeNational Cancer InstituteServierUniversitat Autònoma de BarcelonaUniversità degli Studi di TorinoUniversität ZürichUmeå UniversitetBar-Ilan UniversityMcGill UniversityUniversity of LeedsViewRayMoffitt Cancer CenterApollomicsSidney Kimmel Comprehensive Cancer CenterPfizerIncyteAstraZenecaNovocureCancer Research UKBoston Scientific CorporationKaryopharm TherapeuticsWayne State UniversityUniversity of Illinois at Urbana-ChampaignMichigan State UniversityAmgenCollege of Engineering, Michigan State UniversityJohns Hopkins UniversityHenry Ford Health SystemVrije Universiteit AmsterdamFocused Ultrasound FoundationUniversity of SussexAlexion PharmaceuticalsEli Lilly and Company
KeywordsLiquid biopsyBiopsyBrain biopsyAnalyteMedicineBrain tumorMedical physicsPathologyInternal medicineChemistryChromatographyCancer

Abstract

fetched live from OpenAlex

This review explores the pivotal role of preanalytical variables in bringing liquid biopsy approaches into the clinic for brain tumors. Preanalytical variables encompass a range of critical issues, from blood sample collection and handling to the impact of tumor heterogeneity and patient-specific factors. These variables introduce challenges such as false positives, false negatives, and variability in the analysis of tumor signals, which can hinder the diagnostic and prognostic utility of liquid biopsies. Understanding the nuances of preanalytical variables is essential for the successful implementation of liquid biopsy in clinical settings. This paper delves into strategies aimed at mitigating the influence of preanalytical variables by emphasizing the importance of standardized sample collection protocols, optimized sample processing and storage, quality control measures, and the integration of multiple liquid biopsy modalities.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.005
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.004
Threshold uncertainty score0.020

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.005
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0040.002
Science and technology studies0.0000.001
Scholarly communication0.0020.002
Open science0.0010.001
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0020.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.026
GPT teacher head0.324
Teacher spread0.298 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicCancer Genomics and DiagnosticsFrench-language works237,207